TLR2 and neoplasm: This increased tumor burden in TLR2−/− mice was further explained by the overactivation of signal transducer and activator of transcription 3 (STAT3) in epithelial cells and the elevated expression of tumor-promoting cytokines, such as IL-6, IL-17A and TNF-α in the gut mucosa.